Special Issue "Biomedical Insights that Inform the Diagnosis of ME/CFS"
Deadline for manuscript submissions: closed (31 May 2019).
A printed edition of this Special Issue is available here.
Interests: infectious disease; pathology; machine learning; statistics; biomarkers; pattern recognition
Interests: mitochondrial biology and disease; neurodegenerative disease; AMPK; TOR complex I; cellular stress signalling
Special Issues and Collections in MDPI journals
Special Issue in Cells: Nonmammalian Models for Neurodegenerative and Neurological Disorders
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, chronic health condition that is often misunderstood or ignored by the health establishment. The lack of definitive diagnostic markers that are used to separate ME/CFS patients from the healthy population, as well as from other chronic disorders, is problematic for both health professionals and researchers.
A consortium of Australian researchers have come together to understand ME/CFS systematically, ranging from a deep analysis of clinical and pathology data, to metabolomic profiles and the investigation of mitochondrial function. From this broad collaboration, a number of compelling insights have arisen that may form the basis of specific serum, blood, and/or urinary biomarkers of ME/CFS.
This Special Edition reports on a conference centred on these biomedical discoveries, and on the translation of these results into tangible, quantitative, and predictive markers, which could diagnose ME/CFS. The conference invites contributions from a range of international collaborators and colleagues, with the aim of sharing the latest results to allow for, as quickly as possible, the identification of disease marker patterns in order to elucidate the underlying biological mechanisms of ME/CFS. It is hoped that by supporting health professionals with developments in diagnostics for this condition, the patients and their families will benefit from an improved recognition of the biomedical underpinnings of the condition, and will be better able to access the care that is urgently required.
The Special Edition contains all of the speaker submissions and other accepted manuscripts contributing to our objective for Biomedical Insights that Inform the Diagnosis of ME/CFS.
ME/CFS. The biological basis, diagnosis, treatment, and management.
International Research Symposium
12–15 March 2019, Australia.
Proudly hosted by Emerge Australia
Dr. Brett Lidbury
Professor Paul Fisher
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.